Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg
Daniel Seehofer
Thorsten Kaiser

Showing results (11-20 of 967) with videos related to

Pageof 97
Sort By:
Plos One|March 24, 2017
Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosisSusen Becker, Benedict Kinny-Köster, Michael Bartels, et al.
Chirurgie (Heidelberg, Germany)|June 30, 2022
[Cholangiocarcinoma-Intrahepatic to hilar bile duct cancer]Sebastian Rademacher, Timm Denecke, Thomas Berg, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Editorial: moving towards a robust definition of sarcopenia in cirrhosis-authors' replyCornelius Engelmann, Stefan Schob, Daniel Seehofer, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 21, 2020
Transient Howell-Jolly-body-like cytoplasmic inclusions in neutrophils after severe intoxication with alpha-lipoic acidPeter Schuff-Werner, Wolfram Pönisch, Thomas Berg, et al.
Journal of Cancer Research and Clinical Oncology|October 25, 2025
Intrahepatic cholangiocarcinoma as a unique subtype: key updates from current guidelinesAaron Schindler, Timm Denecke, Daniel Seehofer, et al.
Surgical Technology International|August 23, 2021
Current State and Future Possibilities in Liver TransplantationSebastian Rademacher, Niklas F Aehling, Robert Sucher, et al.
Journal of Hepatology|December 18, 2023
Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD scoreMagdalena Hahn, Adam Herber, Thomas Berg, et al.
Hepatobiliary Surgery and Nutrition|March 2, 2023
The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumabSabine Lieb, Sebastian Ebel, Daniel Seehofer, et al.
Hepatology Communications|April 14, 2022
Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosisCornelius Engelmann, Niklas F Aehling, Stefan Schob, et al.
Plos One|July 5, 2013
Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis BMelanie Maier, Uwe G Liebert, Christian Wittekind, et al.
Pageof 97

Showing results (11-20 of 967) with videos related to

Sort By:
Pageof 97
Plos One|March 24, 2017
Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosisSusen Becker, Benedict Kinny-Köster, Michael Bartels, et al.
Chirurgie (Heidelberg, Germany)|June 30, 2022
[Cholangiocarcinoma-Intrahepatic to hilar bile duct cancer]Sebastian Rademacher, Timm Denecke, Thomas Berg, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2019
Editorial: moving towards a robust definition of sarcopenia in cirrhosis-authors' replyCornelius Engelmann, Stefan Schob, Daniel Seehofer, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 21, 2020
Transient Howell-Jolly-body-like cytoplasmic inclusions in neutrophils after severe intoxication with alpha-lipoic acidPeter Schuff-Werner, Wolfram Pönisch, Thomas Berg, et al.
Journal of Cancer Research and Clinical Oncology|October 25, 2025
Intrahepatic cholangiocarcinoma as a unique subtype: key updates from current guidelinesAaron Schindler, Timm Denecke, Daniel Seehofer, et al.
Surgical Technology International|August 23, 2021
Current State and Future Possibilities in Liver TransplantationSebastian Rademacher, Niklas F Aehling, Robert Sucher, et al.
Journal of Hepatology|December 18, 2023
Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD scoreMagdalena Hahn, Adam Herber, Thomas Berg, et al.
Hepatobiliary Surgery and Nutrition|March 2, 2023
The CRAFITY score can identify patients with hepatocellular carcinoma showing poor response to treatment with atezolizumab and bevacizumabSabine Lieb, Sebastian Ebel, Daniel Seehofer, et al.
Hepatology Communications|April 14, 2022
Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosisCornelius Engelmann, Niklas F Aehling, Stefan Schob, et al.
Plos One|July 5, 2013
Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis BMelanie Maier, Uwe G Liebert, Christian Wittekind, et al.
Pageof 97